![Bruno Stutzmann](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bruno Stutzmann
Chief Executive Officer at Catalent France Beinheim SA
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Steven Fasman | M | 62 |
Catalent France Beinheim SA
![]() Catalent France Beinheim SA Pharmaceuticals: MajorHealth Technology Catalent France Beinheim SA is engaged in softgel development and manufacturing operations. It offers formulation development and manufacturing services for controlled substances, highly potent compounds, and hormones. The firm’s technologies include optiform® solution suite, optigel™ bio, and rp scherer softgel technology. The company was founded on May 3, 1965 and is headquartered in Beinheim, France. | - |
Aristippos Gennadios | M | 59 |
Catalent France Beinheim SA
![]() Catalent France Beinheim SA Pharmaceuticals: MajorHealth Technology Catalent France Beinheim SA is engaged in softgel development and manufacturing operations. It offers formulation development and manufacturing services for controlled substances, highly potent compounds, and hormones. The firm’s technologies include optiform® solution suite, optigel™ bio, and rp scherer softgel technology. The company was founded on May 3, 1965 and is headquartered in Beinheim, France. | - |
Wetteny Joseph | M | 52 |
Catalent France Beinheim SA
![]() Catalent France Beinheim SA Pharmaceuticals: MajorHealth Technology Catalent France Beinheim SA is engaged in softgel development and manufacturing operations. It offers formulation development and manufacturing services for controlled substances, highly potent compounds, and hormones. The firm’s technologies include optiform® solution suite, optigel™ bio, and rp scherer softgel technology. The company was founded on May 3, 1965 and is headquartered in Beinheim, France. | - |
Thomas Castellano | M | 45 |
Catalent France Beinheim SA
![]() Catalent France Beinheim SA Pharmaceuticals: MajorHealth Technology Catalent France Beinheim SA is engaged in softgel development and manufacturing operations. It offers formulation development and manufacturing services for controlled substances, highly potent compounds, and hormones. The firm’s technologies include optiform® solution suite, optigel™ bio, and rp scherer softgel technology. The company was founded on May 3, 1965 and is headquartered in Beinheim, France. | - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
France | 4 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Bruno Stutzmann
- Personal Network